Coagulation marker | Advanced breast cancer | Early breast cancer | Control | p ANOVA (Scheffe-showing paired comparisons) |
---|---|---|---|---|
sVEGF μg/ml, geometric mean (CI)[n] | 344.0 (270.7-437.2)*†[35] | 181.0 (155.9-210.2)* [86] | 28.8 (25.3-32.8)†[61] | <0.001 (*<0.001, †<0.001) |
pVEGF μg/ml, geometric mean (CI)[n] | 22.8 (17.6-29.4)*†[35] | 14.2 (12.1-16.6)* [86] | 15.1 (12.7-17.9)†[61] | 0.004 (*0.01, †0.03) |
Platelet count × 109/l, mean (CI) [n] | 326.7* (286.9-366.5) [36] | 309.6 (293.0-326.2) [87] | 278.6 (257.7-299.6)* [45] | 0.04 *0.05 |
Platelet VEGF VEGF μg/ml per platelet × 109 median (range) [n] | 1.02*†‡ (0.17-3.53) [35] | 0.53* (0.05-2.89) [83] | 0.53 ‡(0.007-2.48) [45] | 0.05 (*<0.001, †0.008, ‡0.002 |